These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25169570)

  • 1. Endocrinology and Metabolism Clinics of North America. HIV and endocrine disorders. Foreword.
    LeRoith D
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):xiii-xv. PubMed ID: 25169570
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
    Kibirige D; Ssekitoleko R
    Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and endocrine disorders.
    Hruz PW
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):xvii-xviii. PubMed ID: 25169571
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine and metabolic disorders associated with human immune deficiency virus infection.
    Unachukwu CN; Uchenna DI; Young EE
    West Afr J Med; 2009 Jan; 28(1):3-9. PubMed ID: 19662737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrinopathies in children infected with human immunodeficiency virus.
    Loomba-Albrecht LA; Bregman T; Chantry CJ
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):807-28. PubMed ID: 25169569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.
    Khalsa JH; Genser S; Coates P; Francis H
    Clin Infect Dis; 2003; 37 Suppl 2():S37-42. PubMed ID: 12942372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine-metabolic changes in patients infected with the human immunodeficiency virus].
    Alvarez Hernández J
    Rev Clin Esp; 1994 May; 194(5):352-60. PubMed ID: 8059033
    [No Abstract]   [Full Text] [Related]  

  • 8. Aging and HIV infection.
    Kohli R; Klein RS; Schoenbaum EE; Anastos K; Minkoff H; Sacks HS
    J Urban Health; 2006 Jan; 83(1):31-42. PubMed ID: 16736353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.
    Cooper OB; Brown TT; Dobs AS
    Clin Infect Dis; 2003; 37 Suppl 2():S132-6. PubMed ID: 12942387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrine involvement in HIV infections].
    Luckhaus J
    Zentralbl Gynakol; 1999; 121(1):30-2. PubMed ID: 10091311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection.
    Capiluppi B; Ciuffreda D; Sciandra M; Marroni M; Tambussi G; Lazzarin A
    AIDS; 2000 Aug; 14(12):1861-2. PubMed ID: 10985329
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Cotter AG; Powderly WG
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrinology and Metabolism Clinics of North America. Pediatric endocrinology. Foreword.
    LeRoith D
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):xi-xiii. PubMed ID: 23099273
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy.
    Bernasconi E; Uhr M; Magenta L; Ranno A; Telenti A;
    AIDS; 2001 May; 15(8):1081-2. PubMed ID: 11400001
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic, endocrine, and gastrointestinal (MEG) disorders in drug abuse and HIV/AIDS. Proceedings of a workshop. August 3-4, 1998.
    Khalsa JH; Genser S; Marriott B; Francis H
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S1-91. PubMed ID: 11126420
    [No Abstract]   [Full Text] [Related]  

  • 17. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Proceedings of a workshop. 26-27 November 2001.
    Clin Infect Dis; 2003; 37 Suppl 2():S37-153. PubMed ID: 14569966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comments: endocrinology and metabolism 2010.
    Root AW
    Curr Opin Pediatr; 2010 Aug; 22(4):467-9. PubMed ID: 20631539
    [No Abstract]   [Full Text] [Related]  

  • 20. Reproduction and fertility in human immunodeficiency virus type-1 infection.
    van Leeuwen E; Prins JM; Jurriaans S; Boer K; Reiss P; Repping S; van der Veen F
    Hum Reprod Update; 2007; 13(2):197-206. PubMed ID: 17099206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.